The tumor strikes back: new data on expression of the CD95(APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology

Cell Death Differ. 1997 Jul;4(5):362-4. doi: 10.1038/sj.cdd.4400252.
No abstract available

Publication types

  • Editorial